Skip to main navigation
Barinthus Biotherapeutics logo
Top Navigation
  • Home
  • About Us
    • Overview
    • Our Team
    • A Name with Purpose
  • Technology
    • Overview
    • Viral Vector Platforms
    • Synthetic Platforms
  • Pipeline
    • Overview
    • Infectious Diseases
    • Autoimmunity
    • Cancer
  • Partnerships
    • Overview
    • Infectious Diseases
    • Autoimmunity
    • Cancer
  • Investors
    • Overview
    • News & Filings
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Investor FAQs
    • Contact IR
  • Careers
    • Overview
    • Working Here
    • Diversity & Inclusion
    • Our Values
    • Recruitment Companies
  • Contact
    • Overview
    • Patient Enquiries
Select Page

RSS Feeds

Toolkit
  • Subscribe
  • RSS Feeds
  • Contact IR
  • Presentations
Sub Nav Investor Resources
Investor FAQs
Subscribe to email alerts
RSS Feeds
Contact IR
RSS Feeds

RSS (Really Simple Syndication) feeds provide an easy way to keep up with news and information about our company. Most web browsers have built in RSS readers, or you can use our feeds in an RSS reader or aggregator.

Latest Press Releases

Latest SEC Filings

Recent Events

Barinthus Biotherapeutics plc

Unit 6-10
Zeus Building
Rutherford Avenue
Harwell OX11 0DF
United Kingdom

T: +44 (0)1865 818808

Footer Links
Home
About
Sitemap
Privacy Policy
Privacy Notice
Careers
Contact
Barinthus Biotherapeutics logo
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.
© Barinthus Biotherapeutics 2026 All rights reserved.
Social Media Links
  • Follow us on X
  • Follow us on LinkedIn